K921476 is an FDA 510(k) clearance for the INTERP-1000.
Submitted by Qmed, Inc. (Laurence Harbor, US). The FDA issued a Cleared decision on October 21, 1992 after a review of 205 days - an extended review cycle.
This device falls under the Cardiovascular FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.
View all Qmed, Inc. devices